BiotechTube

VERU-111

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

SARS-CoV Infection

Conditions

SARS-CoV Infection

Trial Timeline

May 18, 2021 → Jul 6, 2022

NCT ID
NCT04842747

About VERU-111

VERU-111 is a phase 3 stage product being developed by Veru for SARS-CoV Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT04842747. Target conditions include SARS-CoV Infection.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT04842747Phase 3Completed
NCT04388826Phase 2Completed
NCT03752099Phase 1/2Terminated

Competing Products

20 competing products in SARS-CoV Infection

See all competitors
ProductCompanyStageHype Score
CT-P59CelltrionPhase 1
33
CT-P63 + PlaceboCelltrionPhase 1
33
CT-P59 + CT-P59 + Placebo + CT-P59 + PlaceboCelltrionPhase 2/3
65
CT-P59 + PlaceboCelltrionPhase 1
33
Edoxaban Tablets + Colchicine TabletsDaiichi SankyoPhase 3
77
S-268019-b + PlaceboShionogiPhase 3
77
S-217622 + PlaceboShionogiPhase 3
77
S-217622 + PlaceboShionogiPhase 3
77
FOY-305 + PlaceboOno PharmaceuticalPhase 3
77
Nitric OxideGlenmark PharmaceuticalsPhase 3
77
Mesenchymal stem cell + PlaceboRohto PharmaceuticalPhase 2
52
EvusheldAstraZenecaPre-clinical
23
Biological: AZD3152 + Biological: PlaceboAstraZenecaPhase 2
52
AZD5156 (Parent study Sentinel Safety Cohort) + Placebo (Parent study Sentinel Safety Cohort) + EVUSHELD™ (Parent study Main Cohort) + AZD3152 (Parent study Main Cohort) + Placebo (Parent study Main Cohort) + AZD3152 (Sub-study) + AZD7442 - EVUSHELD™ (Sub-study) + AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152AstraZenecaPhase 2/3
65
EVUSHELDAstraZenecaPre-clinical
23
AZD1222AstraZenecaApproved
85
AZD3152 (Cohort 1) + Placebo (Cohort 1) + AZD3152 (Cohort 2) + Placebo (Cohort 2) + AZD3152 (Cohort 3) + Placebo (Cohort 3)AstraZenecaPhase 1
33
EVUSHELDAstraZenecaPre-clinical
23
AZD7442AstraZenecaPhase 1
33
EVUSHELDAstraZenecaPre-clinical
23

Other Products from Veru

VERU-111 + Enzalutamide, AbirateronePhase 3
69
Enobosarm & Abemaciclib Combo + non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or FulvestrantPhase 3
69
Enobosarm + ExemestanePhase 3
69
Sabizabulin + Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulatorPhase 2
44
Enobosarm + SemaglutidePhase 2
44